A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer
Year: 2010
Type: article
Study design: Clinical Trial
Source: Gynecologic Oncology
Institutions: Prince of Wales Hospital, Texas Oncology, Mercy Hospital for Women
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: GlaxoSmithKline
OpenAlex ID: W1994855668
